San Diego, CA, United States of America

Tien-Li Lee

USPTO Granted Patents = 7 

Average Co-Inventor Count = 1.2

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • San Diego, CA (US) (2001 - 2020)
  • Millbrae, CA (US) (2021)

Company Filing History:


Years Active: 2001-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Tien-Li Lee

Introduction

Tien-Li Lee is a notable inventor based in San Diego, CA, who has made significant contributions to the field of medical research. He holds a total of 7 patents, showcasing his innovative approaches to treating serious health conditions.

Latest Patents

Among his latest patents, Lee has developed a method for treating SARS and preventing Acute Respiratory Distress Syndrome (ARDS). This invention includes compositions and methods that demonstrate significant efficacy in an acute lung injury model. The test compound, denatonium acetate monohydrate, has shown promise in treating ARDS and SARS caused by coronaviruses. Additionally, he has created oral pharmaceutical formulations of bitter compounds aimed at treating pulmonary hypertension. These formulations include various bitter agents and PDE-5 inhibitors, highlighting his innovative approach to complex medical challenges.

Career Highlights

Throughout his career, Tien-Li Lee has worked with several companies, including Aardvark Therapeutics, Inc. and Cellics Therapeutics, Inc. His work has focused on developing effective treatments for serious respiratory conditions, contributing to advancements in medical science.

Collaborations

Lee has collaborated with various professionals in the field, including his coworker Zhenhuan Zheng, who has also contributed to his research endeavors.

Conclusion

Tien-Li Lee's innovative work and patents reflect his dedication to improving healthcare through scientific research. His contributions are paving the way for new treatments that could significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…